INmune Bio

INmune Bio
INmune Bio

INmune Bio Inc. is a clinical stage biotechnology company that is developing new immunotherapies that reprogram a patient’s innate immune system to allow the immune system to fight cancer. Our drug candidates, INKmuneTM and INB03, may be used alone or with conventional therapies to help eliminate disease in a wide variety of cancers. We believe they can also boost the effectiveness of other immunotherapies designed to enhance immune response to specific tumors.

Stories by INmune Bio